Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial

Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial

Abstract Objectives As of December, 1st, 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, resulted in more than 1 472 917 deaths worldwide and death toll is still increasing exponentially. Many COVID-19 infected people are asymptomatic or experience moderate symptoms and recover witho...

Full description

Bibliographic Details
Main Authors: W. Dioh, M. Chabane, C. Tourette, A. Azbekyan, C. Morelot-Panzini, L. A. Hajjar, M. Lins, G. B. Nair, T. Whitehouse, J. Mariani, M. Latil, S. Camelo, R. Lafont, P. J. Dilda, S. Veillet, S. Agus
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Trials
Subjects:
COVID-19
SARS-CoV2
randomised controlled trial
Renin Angiotensin System
Mas receptor
angiotensin converting enzyme-2
Online Access:https://doi.org/10.1186/s13063-020-04998-5

Internet

https://doi.org/10.1186/s13063-020-04998-5

Similar Items